Acacia Research (ACTG) Cash & Equivalents (2009 - 2026)

Acacia Research's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $307.5 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 13.07% year-over-year to $307.5 million; the TTM figure through Mar 2026 stood at $307.5 million (up 13.07% YoY), while the FY2025 annual figure was $306.7 million, up 11.99% from the prior year.
• Cash & Equivalents was $307.5 million for Q1 2026 at Acacia Research, roughly flat from $306.7 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $438.8 million in Q1 2024 to a low of $241.9 million in Q3 2022.
• Historically, Cash & Equivalents has averaged $320.7 million across 5 years, with a median of $307.5 million in 2026.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents surged 99.83% in 2022, then plunged 38.02% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $287.8 million in 2022, then advanced by 18.17% to $340.1 million in 2023, then decreased by 19.47% to $273.9 million in 2024, then gained by 11.99% to $306.7 million in 2025, then grew by 0.26% to $307.5 million in 2026.
• The last three Cash & Equivalents figures came in at $307.5 million (Q1 2026), $306.7 million (Q4 2025), and $301.8 million (Q3 2025), per Business Quant data.